Yasser Khaled, MD, is the Medical Director of the Blood and Marrow Transplant Program, a collaboration between Methodist Healthcare, West Cancer Center, and the University of Tennessee Health Science Center.
Titles and Roles
- Medical Director, Methodist Healthcare Blood and Marrow Transplant Center
Areas of Expertise
- Blood and Bone Marrow Transplantation
- Medical Hematology
Prior to coming to Memphis, Dr. Khaled served as Medical Director of the Bone and Marrow Transplant Program at Florida Hospital in Orlando, Florida. During his tenure there, the BMT program established itself as the 2nd largest in the state, with survival outcomes that significantly exceeded the national average. Prior to that, Dr. Khaled served as the faculty member at the Blood and Marrow Transplant Program at the University of Michigan in Ann Arbor. Dr. Khaled has a strong interest in research, with more than 70 regional and national presentations on stem cell transplantation and multiple myeloma.
Education and Training
Dr. Khaled earned his Medical Degree from the Cairo University School of Medicine in Cairo, Egypt. He fulfilled his internship with the Transitional Departments in the Cairo University Hospitals in Cairo, Egypt. He went on to complete his residency in internal medicine with Miser International Hospital in Cairo, Egypt, as well as Woodhull Medical Center in Brooklyn, New York. Dr. Khaled then took part in three fellowships: the first with Virginia Commonwealth University in the Department of Medical Oncology, the second with New York Medical College in the Department of Hematology, and the third with University of Texas M.D. Anderson Cancer Center in the Department of Blood & Bone Marrow Transplantation.
- “America’s Top Oncologists” by Consumer Research Council, 2009-2011
- American Society of Clinical Oncology (ASCO)
- American Society of Hematology (ASH)
- American Society for Blood and Marrow Transplantation (ASBMT)
- Lymphoma Leukemia Society Board of Trustees, North and Central Florida Chapter
Dr. Khaled has a long standing research career. Most recently, he was involved in research concerning:
- Guilain-Barre’ syndrome (GBS) post adult cord blood transplantation in a patient with chronic lymphocytic leukemia (CLL)
- Effect of mobilization method on immune reconstitution post high dose chemotherapy and autologous stem cell transplantation
- Low dose thymoglobulin result in improved outcomes after allogeneic unrelated hematopoietic stem cell transplantation (HCT) for patients with acute myeloid leukemia/ myelodysplastic syndrome conditioned with intravenous busulfan and fludarabine
Dr. Khaled has more than 60 published articles and abstracts including publications in high-impact journals such as Blood, the Journal of Clinical Oncology, and Bone Marrow Transplantation.
To view Dr. Khaled’s most recent publications, click here.